EXOSC2

EXOSC2 Full Name

exosome component 2

EXOSC2 Introduction

Exosome Component 2 (EXOSC2) is an essential structural subunit of the highly conserved RNA exosome complex, a multi-protein machinery responsible for RNA processing, quality control, and degradation in eukaryotic cells. Although EXOSC2 itself lacks catalytic activity, it forms part of the exosome cap that recognizes and channels RNA substrates into the core of the complex for controlled processing. This function is critical for maintaining RNA homeostasis by regulating the maturation and turnover of pre-mRNAs, rRNAs, snRNAs, snoRNAs, and numerous non-coding RNAs. Because accurate RNA surveillance underpins virtually every aspect of gene expression, EXOSC2 has become an important target in studies of RNA biology, transcriptome regulation, and molecular genetics.

EXOSC2 plays a central role in preserving transcriptome integrity by supporting the assembly and stability of the RNA exosome and facilitating the recognition of newly synthesized or defective RNA molecules. Through coordinated RNA degradation and processing, the exosome prevents the accumulation of aberrant transcripts that could interfere with RNA splicing, ribosome biogenesis, transcription termination, and genome stability. Functional studies have demonstrated that loss of EXOSC2 disrupts exosome-mediated RNA metabolism, resulting in widespread defects in RNA processing. Animal models further show that EXOSC2 is indispensable for early mammalian development, as complete deficiency causes embryonic lethality shortly after implantation, underscoring its fundamental role in cellular viability and developmental regulation.

Growing genetic and clinical evidence links EXOSC2 variants to short stature, hearing loss, retinitis pigmentosa, and distinctive facies (SHRF) syndrome, a rare multisystem developmental disorder characterized by growth impairment, sensorineural hearing loss, retinal degeneration, developmental delay, and characteristic craniofacial features. Current research suggests that pathogenic EXOSC2 mutations impair the processing and degradation of pre-mRNAs and small nuclear RNAs, leading to abnormal RNA accumulation, defective RNA splicing, and tissue-specific dysfunction, particularly in the retina and nervous system. Ongoing investigations also indicate that altered interactions between EXOSC2 and other RNA exosome cofactors may contribute to disease-specific phenotypes. As RNA metabolism becomes an increasingly important focus in precision medicine, EXOSC2 is emerging as a valuable target for studies of rare genetic diseases, neurodevelopmental disorders, RNA surveillance mechanisms, and future RNA-based therapeutic strategies.

Alternate Names for EXOSC2

EXOSC2; exosome component 2; p7; RRP4; Rrp4p; hRrp4p; exosome complex component RRP4; exosome complex exonuclease RRP4; ribosomal RNA-processing protein 4; homolog of yeast RRP4 (ribosomal RNA processing 4), 3-5-exoribonuclease

• 1.Ogami K, Suzuki HI. Nuclear RNA Exosome and Pervasive Transcription: Dual Sculptors of Genome Function. Int J Mol Sci. 2021, 22(24):13401.
  2.Morton DJ, et al.; The RNA exosome and RNA exosome-linked disease. RNA. 2018, 24(2):127-142.